Publications

Publications (66 peer-reviewed articles: 61 Research articles + 6 Review Articles):

      1. Merzak, A., McCrea, S., Koocheckpour, S., Pilkington, G.J.: Control of human brain tumour        cell   proliferation, migration, and invasion in vitro by Transforming Growth Factor beta 1. Br. J. Cancer. 70: 199-203, 1994.
      2. Merzak, A., Koocheckpour, S., Pilkington, G.J.: CD44 mediates human glioma cell invasion        and adhesion in vitro. Cancer Res. 54: 3988-3992, 1994
      3. Merzak, A., Koochekpour, S., Pilkington, G.J.: Cell surface gangliosides are involved in the        control of glioma cell invasion in vitro. Neurosci. lett. 177: 44-46, 1994.
      4. Merzak, A., Parker, C., Koochekpour, S., Sherbet, G., Pilkington, G.J.: Overexpression of the 18/A2mts1 gene and down regulation of the TIMP-2 gene in invasive human glioma cell lines in vitro. Neuropath. Appl. Neurobiol., 20: 614-619, 1994.
      5. Koochekpour, S., Merzak, A., Pilkington, G.J.: Control of glioma cell proliferation, morphology, and migration by basement membrane (BM) in vitro. European J. Cancer, 31,   375-380, 1995.
      6. Koochekpour, S., Merzak, A., Pilkington, G.J.: Growth factors and gangliosides stimulate        laminin production by human glioma cells in vitro. Neurosci. lett., 186, 53-56, 1995.
      7. Merzak, A., Koochekpour, S., Pilkington, G.J.: Adhesion of human glioma cell lines to fibronectin, Laminin, vitronectin, and collagen I is modulated by gangliosides in vitro. Cell        Adhesion and Communication, 3, 27-43,  1995.
      8. Merzak, A., Koochekpour, S., McCrea, S., Roxanis, I., Pilkington, G.J.: Gangliosides modulate        proliferation, migration, and invasion of human brain tumour cells in vitro. Mol. Chem.        Neuropathol., 24, 121-135, 1995.
      9. Merzak, A., Koochekpour, S., Dkhissi, F., Rynal, S., Lawrence, D., Pilkington, G.J.: Synergism between growth factors in the control of glioma cell proliferation, migration, and invasion in vitro. Int. J.Oncol., 6, 1079-1085, 1995.
      10. Koochekpour, S., Pilkington, G.J and Merzak, A.: Hyaluronic acid / CD44H interaction        induces cell detachment and stimulates migration and invasion of human glioma cells in        vitro. Int J Cancer: 63, 450-455, 1995.
      11. Koochekpour, S., Pilkington, G.J., Merzak, A.: Vascular endothelial growth factor production is stimulated in response to growth factors in human glioma cells. Oncology Report: 2, 1059-1061, 1995.
      12. Koochekpour, S., Pilkington, G. J., Merzak, A.: Expression of VEGF in human brain tumour cyst fluids. Oncology Report: 2, 1147-1149, 1995.
      13. Merzak, A., Koochekpour, S., Marie-Paule Fillion., Gilles Fillion., Pilkinigton, G. J.:        Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: a        possible role in           glioma cell proliferation and migration. Mol Brain Res: 41, 1-7, 1996
      14. Maidment, S., Merzak, A., Koochekpour, S., Rooprai, H., Rucklidge, G., Pilkington, G.J.: Gangliosides stimulate metalloproteinase expression in human glioma cell lines in vitro. Eur J Cancer: 32A, No.5, 868-871, 1996.
      15. Koochekpour, S . and Pilkington G.J.: Hyaluronic acid modulates human glioma cells proliferation through CD44H in vitro. Oncology Reports: 3, 133-135, 1996
      16. Koochekpour, S., Merzak, A., Pilkington, G.J.: Vascular endothelial growth factor production is stimulated by gangliosides and TGF-β isoforms in human glioma cells in vitro. Cancer Letters:        102, 209-215, 1996.
      17. Koochekpour, S. and Pilkington, G. J.: Vascular and perivascular GD3 expression in human glioma. Cancer Letters, 104, 97-102, 1996.
      18. Koochekpour, S., Jeffers, M., Rulong, S., Taylor, G., Klineberg, E., Hudson, E.A., Resau,J.H. and Vande Woude, G.F.: Met and Hepatocyte Growth Factor expression in Human Gliomas. Cancer Research: 57, 5391-5398, 1997.      
      19. Jeffers, M., Koochekpour, S., Fiscella, M., Sathyanarayana and Vande Woude, G.F.: Signaling Requirements for Oncogenic Forms of the Met Tyrosine Kinase receptor.  Oncogene, 17:2691-2700, 1998.
      20. Jeffers, M., Fiscella, M., Webb, C.P., Anver, M., Koochekpour, S., and Vande Woude, G.F.: The mutationally activated Met receptor mediates motility and metastasis.  Proc. Natl. Acad. Sci. USA, 95:14417-14422, 1998.
      21. koochekpour, S., Jeffers, M., Wang, P.H., Gong, C., Taylor, G.A., Roessler, L.M., Stearman,   R., Stetler-Stevenson, W.G., Kaelin Jr., W.G., Linehan, W.M., Klausner, R.D., Gnarra, J.R.,          and Vande Woude, G.F: The VHL Tumor Suppressor Gene Inhibits HGF/SF-Induced Invasion   Branching Morphogenesis in Renal Carcinoma Cells.  Mol. Cell. Biol., 19, 9: 5902-5912, 1999.
      22. Webb, C. P., Hose, C. D., Koochekpour, S., Jeffers, M., Oskarsson, M., Sausville, E., Monks,   A.and Vande Woude, G.F. The geldanamycins are potent inhibitors of the HGF/SF-Met-uPA-       Plasmin proteolytic network. Cancer Research, 60, 2: 342-349, 2000.
      23. Topol, L.Z., Modi, W.S., Koochekpour, S.and Blair, D.G. DRM/GREMLIN (CKTSF1B1)             maps to human chromosome 15 and is highly expressed in adult and fetal brain. J.             Cytogenetics & Cell Genetics, 89, 1-2:79-84, 2000.
      24. Duesbery, N.S., Resau, J., Webb, C. P., Koochekpour, S., Koo, H. M., Leppla, S.H ., Vande        Woude, G.F. Suppression of ras-mediated transformation and inhibition of tumor growth and        angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc.        Natl. Acad. Sci. USA, 27: 98 (7):4089-4094, 2001.
      25. Koochekpour, S., Maresh, G., Katner, A., Parker-Johnson, K., Lee, T-J., Hebert, F. E., Kao,                  Y.,     and Rayford, W. Establishment and characterization of a primary African-American                  prostate     cancer cell line, E006AA. Prostate, 60: 141-152, 2004
      26. Koochekpour, S., Sartor, O., Lee, T-J., Zieske, Arthur., Patten, D. Y., Hiraiwa, M., Sandhoff, K., Remmel, N., Minokadeh, A. Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells. Prostate, 61: 114-123, 2004.  
      27. Sartor, O and Koochekpour, S. Stem Cells and Prostate Cancer. Clin. Prostate. Cancer, 3: 11-12, 2004.
      28. Lee, T-J., Sartor, O., Luftig, R. B., Koochekpour, S. Saposin C promotes survival and  prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells. Mol. Cancer, 3: 31, 2004.
      29. Gandhok, N. K., Looney S., Koochekpour, S., and Sartor, O. Relationships between reverse transcriptase-polymerase chain reaction for prostate specific antigen, survival, and various prognostic laboratory factors in patients with hormone refractory prostate cancer. Urol. Oncol, 23:163-167, 2005
      30. Koochekpour, S, Sartor, O, Hiraiwa, M, Lee, T-J, Rayford, W, Remmel, N, Sandhoff, K, Minokadeh, A, Patten, D.Y. Saposin C Stimulates Growth and Invasion, Activates p42/44 and SAPK/JNK Signaling Pathways of MAPK and Upregulates uPA/uPAR Expression in Prostate Cancer and Stromal Cells. Asian. J. Androl, 7, 147-158, 2005.
      31. Koochekpour, S, Zhuang, Yu-Jun, Beroukhim, R, Hssieh C-L, Zhau, HE, Hiraiwa, M, Pattan,      D, Ware, J. L, Sandhoff, K, Sawyers, C. L, Pienta K.J, Rubin MA, Vessella RL, Sellers WR,   and Sartor, O.  Amplification and Overexpression of Prosaposin in Prostate Cancer and Other Malignant Cells. Genes, Chromosomes & Cancer, 44, 351-364, 2005.
      32. Koochekpour S. PSAP (Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy)). AtlasGenetCytogenetOncolHaematol,10:370-384,2006. URL:http://www.infobiogen.fr/services/chromcancer/Genes/PSAPID42980ch10q22.html
      33. Baghai-Wadji, M., Sianati, M., Nikpour, H., Koochekpour, S. Pleomorphic adenoma of the trachea in an 8-year-old boy: a case report. J. Pediatric Surg. 41 (8): e23-28, 2006.
      34. Koochekpour, S., Lee, T-J., Wang, R., Sun, Y., Delorme, N., Caffey, S., Grabowski, GA., Culig, Z., Minokadeh, A. Prosaposin is a novel androgen-target gene. J Cell Biochem. 101 (3):631-41, 2007.
      35. Koochekpour, S., Lee, T-J., Wang, R., Vadlamudi, R. K., Culig, Z., Delorme, N., Caffey, S., Marrero, L., Aguirre, J., Garcia, M.Z. Prosaposin Upregulates Androgen Receptor Expression and Activity In Prostate Cancer Cells (LNCaP), Prostate, 67, 178-189, 2007.
      36. Sujit S. Nair, Mueller, J. M., Koochekpour, S., Qiu, Y., Tekmal, R. R., Schüle, R., Kung, H-J., Kumar, R., and Vadlamudi, R. K. PELP1/MNAR modulates transactivation of LIM-only coactivator FHL2. Mol. Endocrinol, 21, 613-624, 2007.                                                        
      37. Koochekpour, S., Lee, T-J., Sun, Y., Hu, S., Grabowski, G. A., Liu, Z., Garay, J. Prosaposin is an   AR-target gene and its neurotrophic domain upregulates SARE expression and activity in prostate stromal cells. J Cell Biochem, 101, 631-641, 2008.        
      38. Singh G, Aras S, Zea AH, Koochekpour S, Aiyar A.Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains. J Virol, 83, 4227-35, 2009.
      39. S, Hu, N, Delorme, Z, Liu, T, Liu, C, Velasco-Gonzalez, J, Garai., A, Pullikuth., and Koochekpour, S. Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion. Molecular Cancer. 9, 30, 2010.
      40. Siyi Hu, Tao Liu, Zhenzhen Liu, Elisa Ledet, Cruz Velasco-Gonzalez, Diptasri M. Mandal,Shahriar Koochekpour. Identification of a Novel Germline Missense Mutation of the Androgen Receptor in African American Men with Familial Prostate Cancer. Asian J Andrology,12 (3): 336-343, 2010.
      41. Koochekpour, S. Comment on "Effect of transferred NK4 gene on proliferation, migration, invasion, and apoptosis of human prostate cancer DU145 cells" by Dan Yue et al. in Asian Journal of Andrology. Asian J Androl. 12(3):444-6, 2010.
      42. D’Antonio, J., Antony, Vander Griend, D. J., L., Dalrymple, S.L., Koochekpour, S., Isaacs, JT.Loss of growth suppression is necessary but not sufficient for prostate cancer cells acquiring oncogen addition to androgen receptor signaling. PLoS One, 5(7):e11475, 2010.
      43. Koochekpour, S. Androgen receptor signaling and mutations in prostate cancer. Asian J.Andrology, 12(5):639-57, 2010. Invited Review Article
      44. Zerfaoui, M., Errami, Y., Suzuki, Y., Naura, A.Y., Ju. J, Liu,T., Hans, C.P., Kim, J., Koochekpour, S., Catling, A., and Boulares, A.H..Poly(ADP-ribose) polymerase-1 is a  determining factor in Crm1-mediated nuclear export of p65 NF-kB and retention upon TLR4 stimulation: a novel mechanism of regulating NF-kB-dependent gene expression. The Journal of Immunology, 185(3):1894-902, 2010.
      45. Koochekpour, S. Genetic and epigenetic changes in human prostate cancer. Iranian Red Crescent Medical journal. 13(2): 80-98, 2011.
      46. Koochekpour, S. DNA methylome and the complexity of prostate cancer biomarker, Asian Journal of Andrology, 13(5):661-2, 2011
      47. Majumdar, s, Buckles, E, John Estrada, and Koochekpour, S. Aberrant DNA methylation in prostate cancer. Current Genomics, 12 (7): 486-505, 2011.
      48. Koochekpour S, Hu S, Vellasco-Gonzalez C, Bernardo R, Azabdaftari G, Zhu G, Zhau HE, Chung LW, Vessella, RL. Serum prosaposin levels are increased in patients with advanced prostate cancer. Prostate. May 31. doi: 10.1002/pros.21427; 72(3): 253-269, 2012.
      49. Koochekpour S, Majumdar S, Azabdaftari G, Attwood K, Scioneaux R, Subramani D,Manhardt C, Lorusso GD, Willard SS, Thompson H, Shourideh M, Rezaei K, Sartor O, Mohler JL, Vessella RL. Serum Glutamate Levels Correlate with Gleason’s Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells. Clinical Cancer Research, 18(21):5888-901, 2012.
      50. Stacey S Willard, Shahriar Koochekpour: Regulators of gene expression as biomarkers for prostate cancer. Am J Cancer Res;2(6):620-657, 2012.
      51. Prabhu V, Srivastava P, Yadav N, Amadori M, Schneider A, Seshadri A, Pitaressi J, Scott R, Zhang H, Koochekpour S, Gogada R, Chandra D. Resveratrol depletes mitochondrial DNA and inhibition of autophagy enhances resveratrol-induced caspase activatio Mitochondrion. Oct 23. doi:pii: S1567-7249(12)00231-0. 10.1016/j.mito.2012.
      52. Siddique HR, Parray A, Zhong W, Karnes RJ, Bergstralh EJ, Koochekpour S, Rhim JS,Konety BR, Saleem M. BMI1 Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer, PLOS ONE, 8(1):e52993. doi:10.1371/journal.pone.0052993, 2013.
      53. Koochekpour, S. Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer. Asian J. Andrology. Research Highlight, 15(2):2012-3, 2013.
      54. Verone AR, Duncan K, Godoy A, Yadav N, Bakin A, Koochekpour S, Jin JP, Heemers HV
        Androgen-responsive Serum Response Factor (SRF) target genes regulate prostate cancer cell migration. Carcinogenesis. 34(8): 1737-46, 2013.
      55. Wilk A, Waligórski P, Lassak A, Vashistha H, Lirette D, Tate D, Zea AH, Koochekpour S, Rodriguez P, Meggs LG, Estrada JJ, Ochoa A, Reiss K. Polycyclic aromatic hydrocarbons - induced ROS accumulation enhances mutagenic potential of T-antigen from human polyomavirus JC. J Cell Physiol. 228(11): 2127-38, 2013.
      56. Willard S, Koochekpour, S. Glutaamte Signaling ijn benign and malignant disorders:Curren Status, future perspectives, and therapeutic implications. Int. J. Biol. Sci. 9(7):728-742. doi:10.7150/ijbs.6475, 2013.
      57. Willard S and Koochekpour, S. Glutaamte, glutamate receptors, and downstream signaling pathways. Int. J. Biol. Sci. 9(9): 948-959, 2013.
      58. Koochekpour S., Marlowe T, Singh KK, Kristopher A, and Chandra D. Reduced mitochondrial DNA (mtDNA) levels associate with poor prognosis of prostate cancer in African American men Koochekpour, S., PLoS One; 23;8(9):e74688. 2013.
      59. Koochekpour S, Buckles E, Shourideh M, Hu S, Dhyan C, Zabaleta J, Attwood K.Androgen receptor mutations and polymorphisms in African American prostate cancer.Int. J. Biol. Sci, 10(6):576-587, 2014.
      60. Collazo J, Zhu B, Larkin S, Horbinski C, Pu H, Martin SK, Koochekpour S, Kyprianou N.Cofilin Drives Cell Invasive and Metastatic Responses to TGF-β in Prostate Cancer. Cancer Res. 74(8):2362-73, 2014.
      61. Koochekpour S, Willard SL, Shourideh M, Ali S, Liu C, Azabdatari A, Saleem M, Attwood K. Establishment and characterizatiojn of a highly tumorigenic subline of the African American prostate cancer cell line, E006AA-hT. Int. J. Biol. Sci, 10(8):834-845, 2014.
      62. Parray A, Siddique HR, Kuriger JK, Mishra SK, Rhim JS, Nelson HH, Aburatani H, Konety BR, Koochekpour S, Saleem M. ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: Study in African-American and Caucasian prostate cancer models. Int J Cancer. doi: 10.1002/ijc.28919, 2014.
      63. Singh PK, Preus L, Hu Q, Yan L, Long MD, Morrison CD, Nesline M, Johnson CS, Koochekpour S, Kohli M, Liu S, Trump DL, Sucheston LE,  and  Campbell MJ. Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients.  Oncotarget, 15; 5(3):824-40, 2014.
      64. Koochekpour S. Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer. Int. J. Biol. Sci.; 10(6): 652-653, 2014. Editorial.
      65. Ali S, Shourideh M, Koochekpour S. Identification of novel GRM1 mutations and single nucleotide polymorphisms in prostate cancer tissues and cell lines.PloS ONE, 9(7):e103204. Doi:10.137/journal.pone.0103204, 2014.
      66. Wang L, Xiong H, Wu F, Zhang Y, Wang J, Zhao L, Guo X, Chang L-J, Zhang Y, You J,  Koochekpour S, Saleem M, Huang H, Lu J, Deng Y. Hexokinase 2-Mediated Warburg Effect Is Required for PTEN and p53-Deficiency Driven Prostate Cancer Growth. Cell Reports. 8(5):1461-74, 2014.
      67. Koochekpour S. Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies). Asian Journal of Andrology, 2014. Invited Commentary.

Presentations (since 2004):

  1. Koochekpour, S., Sartor, O., Lee, T-J., Sandhoff. K., Remmel, N., Minokadeh, A., and Patten,   D. Y. Saposin C stimulates migration and invasion and upregulates uPA/uPAR and cathepsin     D expression in human prostate stromal and cancer cells.
    95nd Annual Meeting, AACR,  Orlando, March 27-31, 2004. 
  2. Lee, T-J., Sartor, O., Lee, T-J., Minokadeh, A., Patten, D. Y., Sun. Y., Grabowski, G. A.,Koochekpour, S. Differential induction of prosaposin promoter by androgen and serum in             human prostate cancer and stromal cells.
    95nd Annual Meeting, AACR,  Orlando, March 27-31, 2004.
  3. Zhihue, X., Ling, J., Edlund, M., Lee, T-J., Koochekpour, S., Marshall, F., and Hsieh, C-L Involvement of cell adhesion molecule L1 in human prostate cancer bone metastasis.
    95nd Annual Meeting, AACR,  Orlando, March 27-31, 2004.
  4. Mukherjee, P. K., Koochekpour, S., Lee, T-J., Grabowski, G. A., Sartor, O., Bazan, N. G. The prosaposin gene downregulates oxidative strees-induced apoptosis in human retinal pigment epithelial cells: Hammerhead ribozymes and proximal promoter studies.
    Association for Research in Vision and Ophthalmology, ARVO 2004, April 25-29, 2004;  poster# 4675.
  5. Koochekpour, S., Sartor, O., Lee, T-J., Hebert, F., Patten, D. Y., and Minokadeh, A.Prosaposin is a novel AR-target gene and upregulates AR/PSA expression in prostate stromal and cancer cells. Abstract #998
    American Urological Association, Annual Meeting, San Francisco, May 8-13, 2004.(Discussed Poster Session)
  6. Nair, S., Seetharaman, B., Schule R, Koochekpour, S., El-Naggar, A., Kumar R., and Vadlamudi R.PELP1/MNAR  Modulates  LIM-only coactivator FHL2 Transactivation Functions.     96th Annual Meeting, AACR, April 16-20, 2005, Anaheim, CA , 2005. Proc Amer Assoc Cancer Res 46: #1279
  7. Kristen Bisanz, Jie Yu, Tae-Jin Lee, Koochekpour, S., Milton W. Datta, Chia-Ling Hsieh. L1 Cell Adhesion Molecule (L1 CAM) Enhances Prostate Cancer Cell Tumorigenicity and Bone Metastasis. 96th Annual Meeting, AACR,  April 16-20, 2005, Anaheim, CA , 2005. Proc Am. Assoc. Cancer. Res 46: # 2917
  8. Koochekpour, S, Francine Hebert, Tae-Jin Lee, Oliver Sartor, Milena Z. Garcia, Luis Marrero, Ying Sun, Gregory A. Grabowski, Sorena Kafai, Jennifer Aguirre, Ardalan Minokadeh, David Y. Pattan. Cross-talk between androgen receptor and prosaposin in prostate cancer and stromal cells supports a potential mechanism for antiandrogen withdrawal syndrome. American Urological Association, Annual Meeting, Atlanta, Georgia. May 20-25, 2006.
  9. Koochekpour, S, Jone Garai, Tae-Jin Lee, Z. Liu, Brian J. Williams, Robert Vessella.    Serum-PSAP, a novel biomarker for prostate cancer progression. Society for Basic Urology Research (SBUR), Nov 20-23, 2008, Arizona, Phoenix
  10. Koochekpour, S, Liu, Z, Liu, T, Hu, S, Ledet, E, Velasco-Gonzalez, C, Mandal, D.             Identification of a novel germline missense mutation in the DNA-binding domain of AR in             several African American patients with familial prostate cancer. Society for Basic Urology Research (SBUR), Nov 5-8, 2009, New Orlean, LA
  11. Koochekpour, S. Prostate Cancer Roundtable. Genetic and familial predispositions. Perspectives in Oncology, Nov 13-15, 2009. Ochsner Health System/LSUHSC-NO
  12. Siyi Hu, N. delorme, Z. Liu, T. Liu, C-Velasco-Gonzalez, J CGarai, A. Pulikuth, S.Koochekpour. PSAP down-modulation decreases metastatic prostate cancer adhesion,migration,invasion. AACR 101 st Annual Meeting April 2010, Washington, DC.
  13. Koochekpour, S, Liu, Z, Liu, T, Hu, S, Ledet, E, Velasco-Gonzalez, C, Mandal, D.Identification of a novel germline missense mutation in the DNA-binding domain of AR in several African American patients with familial prostate cancer. Louisiana NCRR/IDeA 2010 Biomedical Research Symposium, Jan 22, 2010, Baton Rouge, LA
  14. Siyi Hu, N. delorme, Z. Liu, T. Liu, C-Velasco-Gonzalez, J Garai, A. Pulikuth, S.   Koochekpour. PSAP down-modulation decreases metastatic prostate cancer adhesion,   migration,invasion. LCRC Annual Scientific Retreat March 26 & 27, 2010. New Orleans,       LA.
  15. Koochekpour, S, Liu, Z, Liu, T, Hu, S, Ledet, E, Velasco-Gonzalez, C, Mandal, D.Identification of a novel germline missense mutation in the DNA-binding domain of AR in several African American patients with familial prostate cancer. NIH, NCRR Third Biennial National IDeA Symposium of Biomedical Research excellence (NISBRE), June 16-18, 2010, Bethesda, Maryland.
  16. Siyi Hu, N. delorme, Z. Liu, T. Liu, C-Velasco-Gonzalez, J CGarai, A. Pulikuth, S.Koochekpour. PSAP down-modulation decreases metastatic prostate cancer adhesion, migration,invasion. NIH, NCRR Third Biennial National IDeA Symposium of Biomedical Research excellence (NISBRE), June 16-18, 2010, Bethesda, Maryland.
  17. S. Koochekpour, SiYi Hu, Vellasco-Gonzalez Cruz, Mohamed El Badri, Ruiz Bernardo, Arthur Zieske, Jill Williams, Leland W. Chung, Haiyen Zhau, Robert L. Vessella, Jone Garai.Prosaposin, a novel biomarker for primary and metastatic prostate cancer, May 15, 2011, 107 th annual meeting, American Urological association.
  18. S. Koochekpour, , S. Hu, Z. Liu, T. Liu, C. Velasco-Gonzalez, E. Buckles, D. Subramania,   S. Majumdar, B. Wood.  Somatic and genomic instability of AR in African Americans with prostate cancer. May 15, 2011, 107 th annual meeting, American Urological association.
  19. S. Koochekpour, S. Majumdar, R. Scioneaux, S.S. Willard, D. Subramani, G.Azabdaftari,   JL. Mohler. Cortisol serum levels are increased and induce genomic instability in   advance prostate cancer. May 19-23, 2012, 108 th annual meeting, American Urological     association.
  20. S. Koochekpour, G. Azabdaftari, K. Attwood, R. Scioneaux, S. Majumdar, D. Subramani, K. Rezaei, J. L. Mohler, O. Sartor, R. L. Vessella. Serum glutamate levels are associated with     primary prostate cancer aggressiveness. May 19-23, 2012, 108 th annual meeting, American      Urological Association. Late-Breaking Abstract.
  21. P. K. Singh, L. Preus, Q. Hu, L. Yan, M. Long, C. Morrison, M. Nesline, C. Johnson, S.Koochekpour, M. Kohli. , S. Liu, D. Trump, M. J. Campbell, L. E. Sucheston. Serum expression levels of microRNA predictthe risk of biochemical failure in prostate cancer.
    Joint Conference of HGM 2013 and 21st International Congress of Genetics (13 – 18 April 2013, Singapore).
  22. Koochekpour. S and J. Zabaleta. Profiles of methylation in normal and malignant prostate tissue reveal differential cellular processes and gene networks associated with disease in African American and Caucasian. Sixth AACR Conference on The Science of Cancer Health  Disparities in Racial/Ethnic Minorities and the Medically Underserved In collaboration with     the AACR Minorities in Cancer Research Council December 6-9, 2013, Atlanta, GA.
  23. Koochekpour, S. Biological and clinical significance of glutamate in prostate cancer.
    9th national symposium on prostate cancer, Clark Atlanta University, March 2013.Invited Speaker.
  24. Koochekpour, S, Marlowe T, Singh KK, Attwood K, and Chandra D. Reduced mitochondrial DNA content is associated with poor prostate cancer prognosis in African American men.Sixth AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved In collaboration with the AACR Minorities in   Cancer Research Council December 6-9, 2013, Atlanta, GA
  25. Duncan K, Pundt K, DePriest A, Verone A, Wang D, Yadav N, Liu S, Tindall DJ, Mohler JL,Koochekpour, S, Heemers HV. Cardiac transcription factors SRF and MEF2A mediate androgen action that is associated with aggressive prostate cancer. WCUR11, 2013.
  26. Koochekpour, S.  Biological and therapeutic implications of glutamate and its receptor (GRM1) in prostate cancer. Society of Basic Urology Research, November 22-25, 2013.
  27. Maahum Ali Haider, Colm Morrissey, Ilsa Coleman, Xiaotun Zhang, Lisha Brown, Lori Kollath, Shahriar Koochekpour, Paul H. Lange, Celestia Higano, Peter Nelson, Daniel W. Lin, Robert    Vessella, Kristopher Attwood, Mogjan Shourideh, Robert B. Montgomery, Lawrence D. True,Martine Roudier. Identifying biomarkers specific to bone metastases in castrate resistant         prostate cancer. ASCO Annual Meeting, May 30-June 3, 2014; Chicago, Illinois. Abstract #     135316.
  28. Maahum Haider, Ilsa Coleman, Xiaotun Zhang, Lisha Brown, Lori Kollath, Shahriar Koochekpour, Robert Montgomery, Paul Lange, Martine Roudier, Lawrence True, Celestia Higano, Peter Nelson, Robert Vessella, Colm Morrissey. Does Tumor Microenvironment Affect the Response of Castration Resistant Prostate Cancer to Therapy in Bone vs Visceral Metastases?            OCCC:  315 Prostate Cancer: Basic Research IV. . May 19-23, 2014, 109 th annual meeting, American Urological Association. Abstract# MP-4915.
  29. Koochekpour S. AR Mutations in African American Prostate Cancer. International Symposium on Minority Health and Health Disparities (ISMHHD), National Institute on Minority and Health Disparities Grantees Conference/ Nov 1-Dec 3rd, 2014. Oral Presentation. Gaylord National Resort and Convention Center, National Harbvor, MD.
  30. Koochekpour S. Developing Cell-based Resources for PCa Disparity Research. International Symposium on Minority Health and Health Disparities (ISMHHD), National Institute on Minority and Health Disparities Grantees Conference/ Nov 1-Dec 3rd, 2014. Gaylord National Resort and Convention Center, National Harbvor, MD.
  31. Koochekpour S. E006AA-hT, a new highly tumorigenic AA-PCa Cell line. International Symposium on Minority Health and Health Disparities (ISMHHD), National Institute on Minority and Health Disparities Grantees Conference/ Nov 1-Dec 3rd, 2014. Gaylord National Resort and Convention Center, National Harbvor, MD.

 

 

Shahriar Koochekpour

Professor
Department of Genetics, Urology, and Oncology

 

  • : 716-845-3345
    Fax: 716-845-1698

  • DEPARTMENTUniversity at Buffalo
  • COUNTRY USA